Bespoke Extracts (BSPK) Net Cash Flow (QoQ) (2012 - 2025)
Bespoke Extracts (BSPK) Net Cash Flow (QoQ) (2012 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Bespoke Extracts | 1.12 Mn | 1.11 Mn | 234,175.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 153.03% |
| Jun 30, 2025 | 3.13% |
| Mar 31, 2025 | -177.05% |
| Dec 31, 2024 | 1,261.39% |
| Sep 30, 2024 | -132.25% |
| Jun 30, 2024 | 32.86% |
| Mar 31, 2024 | 18.19% |
| Dec 31, 2023 | 439.34% |
| Sep 30, 2023 | 19.48% |
| Jun 30, 2023 | 87.95% |
| Mar 31, 2023 | -247.82% |
| Dec 31, 2022 | 102.92% |
| Sep 30, 2022 | -221.93% |
| Jun 30, 2022 | 806.39% |
| Nov 30, 2021 | 95.14% |
| Aug 31, 2021 | 76.01% |
| May 31, 2021 | -271.97% |
| Feb 28, 2021 | 84.83% |
| May 31, 2020 | -22.20% |
| Feb 29, 2020 | -151.32% |